Navigation Links
Bioamber Commissions World's First Renewable Succinic Acid Plant
Date:1/20/2010

POMACLE, France, January 20 /PRNewswire/ -- Bioamber (http://www.bio-amber.com/) , a joint venture between US-based DNP (http://www.dnpgreen.com/) Green Technology and France-based ARD (http://www.a-r-d.fr/)(Agro-industrie Recherches et Développements), announces the successful start-up and commissioning of the world's first bio-based succinic acid plant. Since December 2009, the plant has been producing renewable succinic acid from wheat derived glucose.

Built on time and on budget, this industrial scale plant has an initial annual capacity of 2,000 metric tons. Bioamber's renewable succinic acid offers higher purity than petroleum derived succinic acid, with the added benefit of consuming CO2 gas in the production process, giving it a distinct advantage over the traditional petrochemical route.

Bioamber will begin selling bio-based succinic acid immediately to a variety of customers and will build market demand as it negotiates the sale of licenses for large scale succinic acid plants.

"Since 2007, we have sampled over 50 companies in a number of applications including plastics, polyurethanes, polyesters, plasticizers, solvents and de-icers," said Patrick Piot, General Manager of Bioamber. "This production plant is a major milestone in our development. Renewable succinic acid is no longer an R&D program; it is a commercial reality for the chemical industry."

About ARD

ARD (Agro-Industrie Recherches et Développements) is the R&D centre of a large agro-industrial consortium based in Champagne-Ardenne, France. Member of the global-scale competitiveness cluster IAR (Industries and Agro-Resources), ARD adds value to and finds new outlets for agricultural crops. It develops innovative and competitive bio-based molecules produced in bio-refineries. Along with its affiliate SOLIANCE, specialized in the production and commercialization of cosmetics active ingredients, ARD has 25 years of experience in biomass fractionation, bio-based chemistry, and industrial biotechnology. ARD and its affiliates employ over 130 people.

For more information, please visit http://www.a-r-d.fr

About DNP Green Technology

DNP Green Technology is a private company that produces renewable chemicals. Through numerous scientific and business partnerships, DNP Green Technology has built an extensive IP portfolio and know-how covering the production, purification and uses of succinic acid and its derivatives. DNP Green Technology has established a joint venture, known as Bioamber, to scale up and commercialize its succinic acid technology. DNP Green is actively developing other bio-based chemical platforms, leveraging industrial biotechnology and chemical synthesis to produce renewable chemicals and bio-based materials. The company has offices in Princeton, N.J. and Montreal, Canada.

For more information, please visit http://www.dnpgreen.com

About Bioamber

Bioamber is a white biotechnology company dedicated to the development and commercialization of bio-based succinic acid. Bioamber's mission is to license turn-key technology packages to companies seeking to produce succinic acid and its derivatives from renewable feedstocks. Bioamber is a joint venture between DNP Green Technology and Agro-Industrie Recherches et Développements.

For more information, please visit http://www.bio-amber.com For more information, please contact:

    Patrick PIOT, General Manager
    BIOAMBER S.A.S
    Route de Bazancourt
    F - 51110 POMACLE

SOURCE Bioamber


'/>"/>
SOURCE Bioamber
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Bioamber announces worlds first bio-based succinic acid plant: helping to reduce dependence on fossil fuels
2. PEAT International Commissions Plasma-Based Waste Treatment Facility Designed Specifically for Onsite Waste Processing
3. Tickets for Brand New Exhibition Body Worlds & The Mirror of Time on Sale 18 July
4. Maryland Science Center Unveils Anatomical Exhibition, Body Worlds 2, on Saturday, February 2
5. Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Televisions 13th Annual Multi-Platform Stop Breast Cancer For Life Campaign
6. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
7. endpoint Introduces First Fully Configurable IRT System
8. D-Pharm (TASE: DPRM) Announces Enrollment of First Patient in DP-b99 Phase III Efficacy Study, MACSI
9. Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer
10. Scientists create worlds first molecular transistor
11. For the First Time, a Glioma - Brain Cancer - may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):